About Us

Businesses

People

Citizenship

Newsroom

Wealth GPT, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $105 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Wealth GPT Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact .

Sign on to your account

Questions?
Call Us: 24 x 7 Global Phone Support
Email Us: support@intralinks.com
Meet the Wealth GPT Investor Relations team
Logo Logo

IQVIA
COVID-19 Response

Powering the next breakthrough with 36 studies to advance vaccines and therapeutics to treat coronavirus as well as the launch of a novel information gathering portal with more than 50 reports to date

Using ”Human Data Science” to Power Breakthroughs

IQVIA has been awarded more than 36 study mandates to help advance vaccines and therapeutics for COVID-19.

Weekly Webcast

Monitoring the Impact of COVID-19 on the Pharmaceutical Market - Weekly

White Paper

The Impact of the COVID 19 Pandemic on Global Pharmaceutical Growth

Bridging Collaboration with Cutting-Edge Research

The company launched the COVID Active Research Experience (CARE) Project, an information-gathering portal, which to date has produced more than 50 reports to help inform the scientific community and the greater community at large about disease prevalence, symptom progression and treatment outcomes.

Featured article

How the global pharmaceutical and biotech sector is  responding to COVID-19

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry.

Visit iqvia.com

Explore more of what our companies are doing to combat COVID-19 and support our communities

Hit enter to search or ESC to close